Anti-SARS-CoV-19 antibodies in children and adults with sickle cell disease: A single-site analysis in New York City

Nancy S Green; Layla Van Doren; Maureen Licursi; Daniel D Billings; Luke A Sandoval; Yona M Z Feit; Eldad A Hod

doi:10.1111/bjh.18294

Anti-SARS-CoV-19 antibodies in children and adults with sickle cell disease: A single-site analysis in New York City

Br J Haematol. 2022 Aug;198(4):680-683. doi: 10.1111/bjh.18294. Epub 2022 Jun 27.

Authors

Nancy S Green^{1

2}, Layla Van Doren², Maureen Licursi¹, Daniel D Billings², Luke A Sandoval³, Yona M Z Feit³, Eldad A Hod³

Affiliations

¹ Department of Pediatrics, Division of Hematology, Oncology and Stem Cell Transplantation, Columbia University Irving Medical Center - New York Presbyterian Hospital, New York, New York, USA.
² Department of Medicine, Division of Hematology and Oncology, Columbia University Irving Medical Center - New York Presbyterian Hospital, New York, New York, USA.
³ Department of Pathology and Cell Biology, Columbia University Irving Medical Center - New York Presbyterian Hospital, New York, New York, USA.

No abstract available

Keywords: antibodies; coronavirus 2019 (COVID-19); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); sickle cell disease; splenic function.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Anemia, Sickle Cell* / epidemiology
Antibodies, Viral
COVID-19*
Child
Humans
New York City / epidemiology
SARS-CoV-2
Severe acute respiratory syndrome-related coronavirus*

Substances

Antibodies, Viral